The chemical class known as α1D-AR Inhibitors encompasses a diverse group of molecules and compounds that have been developed and studied for their ability to modulate the activity of the α1D-adrenergic receptors (α1D-AR). These receptors are a subtype of adrenergic receptors that play a role in regulating vascular smooth muscle contraction and cardiovascular functions. α1D-AR Inhibitors are meticulously designed to interact with α1D-AR or related pathways, with the aim of disrupting their signaling and functional activities. By targeting α1D-AR, these inhibitors provide a means to investigate and manipulate the intricate mechanisms that govern vascular tone and other physiological responses.
The study of α1D-AR Inhibitors contributes to advancing our understanding of cardiovascular dynamics, shedding light on the molecular intricacies that impact blood pressure regulation and vascular homeostasis. Ongoing research endeavors continue to unravel the mechanisms of action and broader implications associated with α1D-AR Inhibitors, thereby enhancing our insights into the fundamental principles that underlie cardiovascular physiology and contribute to overall cardiovascular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BMY 7378 dihydrochloride | 21102-95-4 | sc-203849 sc-203849A | 10 mg 50 mg | $97.00 $302.00 | ||
A selective antagonist of α1D-AR that has been used to study its role in vascular and smooth muscle function. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $500.00 | ||
While primarily known as a Gαq inhibitor, YM-254890 can also inhibit α1D-AR signaling. | ||||||
CP 135807 | 151272-90-1 | sc-361155 sc-361155A | 10 mg 50 mg | $169.00 $681.00 | ||
A selective antagonist of α1D-AR that has been used to study its role in cardiovascular physiology. | ||||||